Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma

被引：0

作者：

Vithayathil, Mathew ^{[1
]}

D'Alessio, Antonio ^{[1
,2
]}

Weinmann, Arndt ^{[3
]}

Galle, Peter ^{[3
]}

Fulgenzi, Claudia Angela Maria ^{[4
]}

Fessas, Petros

Bettinger, Dominik ^{[5
]}

Bengsch, Bertram ^{[5
]}

Vogel, Arndt ^{[6
]}

Balcar, Lorenz ^{[7
]}

Scheiner, Bernhard ^{[7
]}

Muzaffar, Mahvish ^{[8
]}

Amara, Suneetha

Muhammed, Ambreen ^{[1
]}

Naqash, Abdul Rafeh

Personeni, Nicola ^{[9
]}

Pressiani, Tiziana

Cammarota, Antonella ^{[2
,9
]}

Pinter, Matthias

Cortellini, Alessio ^{[10
]}

Rimassa, Lorenza ^{[2
,9
]}

Pinato, David J. ^{[11
]}

Sharma, Rohini ^{[1
]}

机构：

[1] Imperial Coll London, London, England

[2] Humanitas Univ, Rozzano, Italy

[3] Johannes Gutenberg Univ Mainz, Univ Johannes Gutenberg, Mainz, Germany

[4] Biomed Campus Univ Hosp, Rome, Italy

[5] Univ Freiburg, Freiburg Univ Med Ctr, Freiburg Im Breisgau, Germany

[6] Hannover Med Sch, Hannover, Germany

[7] Med Univ Vienna, Vienna, Austria

[8] East Carolina Univ, Greenville, NC USA

[9] Humanitas Res Hosp, Cascina Perseghetto, Italy

[10] Univ LAquila, Laquila, Italy

[11] Univ Piemonte Orientale, Vercelli, Italy

来源：

JOURNAL OF HEPATOLOGY | 2022年 / 77卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

THU571

引用

页码：S374 / S375

页数：2